Dr. Nisha Hariharan

Qualifications: HBNI Tata Fellowship (Breast Oncology), MS.

Areas of Specialization:

Profile:

Dr. Nisha Hariharan is a highly experienced Consultant and Breast Oncoplastic surgeon with over a decade of experience in the field. Currently, she manages her own unit at Basavatarakam Indo-American Cancer Hospital in Hyderabad. 

Dr. Nisha received her surgical degree from Grant Medical College and Sir. J. J. Group of Hospitals, Mumbai and then went on to complete a certified HBNI Fellowship in Breast Oncology at Tata Memorial Hospital. She has previously held positions at S.L Raheja Hospital and Apollo Hospitals, Mumbai. 

Her clinical expertise includes conservative breast cancer surgeries, sentinel node biopsies and early detection of disease. She is highly skilled in oncoplastic techniques, consistently achieving strong oncological control along with excellent cosmetic outcomes. She routinely undertakes localized breast conservation following chemotherapy, including targeted axillary dissection when indicated. She also counsels women with hereditary risk or a significant family history of breast cancer and plans risk-reducing prophylactic mastectomies with whole-breast reconstruction in coordination with the plastic surgery team. She is an active member of the multidisciplinary tumor board, contributing to complex, individualized treatment planning.

Dr. Nisha is a well-respected member of the medical community, having presented her work at several national and international conferences including the European Society of Oncology, Union for International Cancer Control, Asian Breast Surgery Forum (Project ECHO), Indian Cancer Congress and the Association of Breast Surgeons of India. She has been a Lead Investigator in multiple national and international clinical trials and is well-trained in clinical research and data analysis. 

In her free time, Dr. Nisha is dedicated to spreading awareness in the community and routinely conducts live discussions and counselling sessions on early detection of breast cancer with women of all ages and backgrounds.

• Global Fellow of the WomenLift Health Leadership program (India cohort 2024-25), supported by the Bill and Melinda Gates Foundation. 
• Associate Editor for the peer reviewed journal International Journal of Surgery: Oncology, Wolters-Kluwer, Lippincott Division 
• India representative in the UICC Regional Dialogue, Asia Pacific, on “Women’s Cancers: Sharing experience, strengthening regional networks” Manila, Philippines, 2023
• Prestigious Dr. P. S. Ghatge Memorial Oration on Innovations and advances in breast cancer treatment: The era of precision oncology, 2023
• UICC Mastercourse Certification in “Access to Essential Cancer Medicines”, August 2023
• UICC Mastercourse certification: “Good practices for planning and implementing breast cancer projects”, December 2022
• Certification in Biostatistics (Linear and logistic regression, survival analysis) and clinical trials (design, analysis and interpretation) Biostatistics Dept, CMC Vellore in association with the University of North Carolina (2015)
• Awarded Best paper presentation: Clinico-pathological data, molecular subtypes and survival analysis in young breast cancer, Indian Cancer Congress 2017, Bangalore, India  
• Awarded by the Govt. of India for Managing victims of the terrorist attack in Mumbai on 26th Nov 2008. Managed first response to mass casualty, bullet injury exploratory laparotomies and the ensuing supportive care

• From exclusion to inclusion: Analysis of patterns of follow-up in breast cancer. International Journal of Surgery Protocols ():10.1097/September 08, 2025. 
• Quality of Life of Informal Caregivers of Newly Diagnosed Breast Cancer Patients in a Cancer-Care Hospital in India: A Longitudinal Study. Breast Global Journal 2(2):p 48-55, April-June 2024(co-author)
• Co-author of the chapter “Approach to Nipple Discharge” In: Dhamija, E., Deo, S.V.S. (eds) Imaging in Management of Breast Diseases. Springer, Singapore.
• Experience of Women Seeking Breast Cancer Care: A Phenomenological Study. Illness, Crisis & Loss, (2025) co-author
• Accuracy of Tumor Bed Biopsy for Predicting Pathologic Complete Response After Chemotherapy Among Women With Breast Cancer: Complete Responders in the Breast Study. JCO Global Oncology. 2023 Sep 
• Intraoperative Margin Assessment in Breast Conservation Surgery: A Necessity or a Luxury?. Ann Surg Oncol (2023). 
• Precision medicine – A new era in multidisciplinary care Cancer Treat Res Commun. 2022;32:100577. 
• Accuracy of core biopsy in predicting pathologic complete response in the breast in patients with complete/near complete clinical and radiologic response (Complete Responders in the Breast- CRBr)- Trial design and conduct. Intl J of Surg Protocols 16(2019) 5-8
• The evolving role of pathologic complete response in breast cancer. South Asian J Cancer 2019;8:210-1. 
• The impact of stage and molecular subtypes on survival outcomes in young women with breast cancer. Journal of Adolescent and Young Adult Oncology Oct 2019, 628-634 
• Survival outcomes in male breast cancer – A single institution experience Asian Pac J Cancer Care, 3(4), 71-74
• Interpectoral tuberculous lymphadenitis masquerading as carcinoma breast: A case report. Indian J Case Reports. 2017;3(4):224-226.
• A Randomized Trial Comparing the Efficacy of Methylene Blue Dye Alone Versus Combination of Methylene Blue Dye and Radioactive Sulfur Colloid in Sentinel Lymph Node Biopsy for Early Stage Breast Cancer Patients. Indian Journal of Surgical Oncology. 11. 10.1007/s13193-019-01023-3.
• Demographic Profile and Prevalence of Comorbidities in newly diagnosed women with breast cancer: Experience from a tertiary care institute. Ann Clin Lab Res Vol. 6 No. 4:270